Phase 2 Lung Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults aged 18 or older who have been diagnosed with advanced non-squamous non-small cell lung cancer (a specific type of lung cancer) that is either at Stage IV or has come back after earlier treatment that was intended to cure it
• People who have already received at least one round of cancer treatment before enrolling
• People whose most recent treatment before joining the trial included a type of drug called a checkpoint inhibitor (a form of immunotherapy)
• People whose general physical functioning is rated at a certain level, meaning they are able to care for themselves and are not completely disabled (confirm with trial site)

Who may not be able to join:

• People whose lung cancer has a specific genetic change (called a driver mutation) that can be targeted by specialised drugs
• People who experienced severe side effects (grade 3 or higher on a standard medical scale) from previous immunotherapy treatment
• People who have another active, unrelated cancer that currently requires treatment
• People who have brain metastases (cancer that has spread to the brain) that are growing or have not yet been treated
• People who have cancer that has spread to the lining around the brain or spinal cord, either currently or in the past
• People who have pain caused by their tumour that is not well controlled
• People with a history of an autoimmune disease (where the immune system attacks the body) or a lung condition called idiopathic pulmonary fibrosis (IPF)

Important: Always verify eligibility with the trial site directly before applying.